Trials / Sponsors / Muhammad Furqan
Muhammad Furqan
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage S Extensive Stage Small Cell Lung Cancer | Phase 2 | 2021-04-20 |
| Withdrawn | PDR001 + Panobinostat for Melanoma and NSCLC Melanoma, Non Small Cell Lung Cancer | Phase 1 | 2019-09-01 |
| Terminated | Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy Non Small Cell Lung Cancer | — | 2019-04-15 |
| Completed | Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer Small Cell Lung Cancer (SCLC) | Phase 2 | 2016-08-29 |